United States · Business magazines · Quartz
GSK beat earnings estimates as specialty medicine sales powered growth
Vaccine sales fell 2% and restructuring charges cut total operating profit 16%, while GSK held its 2026 guidance
Read the full article on Quartz Sign in to saveMarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (qz.com)




